Aim: To determine the transcriptional proximity of retinal pigment epithelium (RPE) cells grown under different culture conditions and native RPE. Methods: ARPE-19 cells were grown under five ...

ONL-1204 is under clinical development by ONL Therapeutics and currently in Phase II for Retinal Pigment Epithelial (RPE) Detachment. According to GlobalData, Phase II drugs for Retinal Pigment ...

Lineage Cell Therapeutics, Inc.’s LCTX share price has surged by 14.78%, which has investors questioning if this is right time to sell.

Fellow-KI researchers Anders Kvanta and Fredrik Lanner have been awarded a grant of SEK 10 million from the Promobilia ...

They result from the degeneration of photoreceptors, retinal pigment epithelial cells, or retinal ganglion cells (RGCs), affecting the outer or inner retina, respectively. The heterogeneity and ...

György. "We observed average editing rates of 75% in cone cells and 87% in retinal pigment epithelial cells. These results far exceed what we believe is necessary to provide clinical benefit to ...

To overcome the challenge, the team used AI and a humanoid for biological experiments to identify the ideal conditions for creating retinal pigment epithelium cells, which supply nutrients to ...

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...

HC Wainwright reaffirmed their buy rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a research note released on Friday,Benzinga reports. HC Wainwright currently has a ...

György. "We observed average editing rates of 75% in cone cells and 87% in retinal pigment epithelial cells. These results far exceed what we believe is necessary to provide clinical benefit to ...